Literature DB >> 9557667

Temporal mapping of transcripts in herpesvirus 6 variants.

P Mirandola1, P Menegazzi, S Merighi, T Ravaioli, E Cassai, D Di Luca.   

Abstract

To define the molecular features characteristic of the early stages of infection of lymphocytes with human herpesvirus 6 (HHV-6) variant A or B, we studied the temporal regulation of expression of selected sets of viral genes. Thus, U42, U94, U89-U90, U73, and U39 are alpha genes since their transcripts (i) were made in the presence of inhibitors of protein synthesis and (ii) were detected 3 h after infection of untreated cells. U41, U53, U31, and U19 are beta genes since their expression is inhibited by cycloheximide but not by phosphonoacetate, an inhibitor of DNA synthesis. U100 is a gamma gene since its spliced transcript encoding the structural glycoprotein gp82/105 was first detected 16 h after infection of untreated cells but could not be detected in cells treated with phosphonoacetate. HHV-6 variants differ in the transcription patterns of their genes. U16-U17 originates a splice transcript and is regulated as alpha in HHV-6B and as beta in HHV-6A. U91 generates two transcripts, amplified as 476- and 374-bp PCR fragments. The 476-bp fragment is alpha in HHV-6A-infected cells but beta in HHV-6B-infected cells. Conversely, the 374-bp fragment is beta in HHV-6A-infected cells and alpha in HHV-6B-infected cells. Furthermore, the spliced product of U18-U19-U20 (526 bp) is beta in HHV-6A-infected cells, but only a partially spliced form (1.9 kb) was detected at late stages of infection in HHV-6B. HHV-6 transcription was also studied in nonproductive lymphoid cells, and the same transcription pattern detected during lytic infection was observed. Also, HHV-6 variants maintain the differences in U91, U16-17, and U18-U19-U20. We conclude that, as expected from the sequencing data, gene expression is generally similar in HHV-6 variants. However, transcription of selected genes in HHV-6A and HHV-6B differs with respect to temporal regulation and splicing pattern. Furthermore, the identification of viral functions expressed during the different stages of lytic replication suggests that reverse transcription-PCR for HHV-6 genes is a useful diagnostic approach to differentiate between latent and productive HHV-6 infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557667      PMCID: PMC109607          DOI: 10.1128/JVI.72.5.3837-3844.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Growth properties of human herpesvirus-6 strain Z29.

Authors:  J B Black; K C Sanderlin; C S Goldsmith; H E Gary; C Lopez; P E Pellett
Journal:  J Virol Methods       Date:  1989-11       Impact factor: 2.014

2.  Isolation of human lymphotropic herpesviruses from Uganda.

Authors:  R G Downing; N Sewankambo; D Serwadda; R Honess; D Crawford; R Jarrett; B E Griffin
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

3.  Human herpesvirus 6 is closely related to human cytomegalovirus.

Authors:  G L Lawrence; M Chee; M A Craxton; U A Gompels; R W Honess; B G Barrell
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

4.  The replication of viral and cellular DNA in human herpesvirus 6-infected cells.

Authors:  D Di Luca; G Katsafanas; E C Schirmer; N Balachandran; N Frenkel
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

5.  Human herpesvirus 6 infection in renal transplantation.

Authors:  T Okuno; K Higashi; K Shiraki; K Yamanishi; M Takahashi; Y Kokado; M Ishibashi; S Takahara; T Sonoda; K Tanaka
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

6.  Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus.

Authors:  K Takahashi; S Sonoda; K Higashi; T Kondo; H Takahashi; M Takahashi; K Yamanishi
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.

Authors:  J C Araujo; J Doniger; F Kashanchi; P L Hermonat; J Thompson; L J Rosenthal
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

Review 9.  Human herpesvirus-6 in transplantation: an emerging pathogen.

Authors:  N Singh; D R Carrigan
Journal:  Ann Intern Med       Date:  1996-06-15       Impact factor: 25.391

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  24 in total

1.  Identification of human herpesvirus 6 latency-associated transcripts.

Authors:  Kazuhiro Kondo; Kazuya Shimada; Junji Sashihara; Keiko Tanaka-Taya; Koichi Yamanishi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Viral gene expression patterns in human herpesvirus 6B-infected T cells.

Authors:  Bodil Øster; Per Höllsberg
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 3.  Split genes and their expression in Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhi-Ming Zheng
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

4.  Long-lasting CD3+ T-cell deficiency after cord blood stem cell transplantation in a human herpesvirus 6-infected child.

Authors:  Manola Comar; Pierlanfranco D'Agaro; Douglas Horejsh; Monica Galvan; Simona Fiorentini; Marino Andolina; Arnaldo Caruso; Dario Di Luca; Cesare Campello
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 5.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Development of reverse transcriptase PCR assays for detection of active human herpesvirus 6 infection.

Authors:  G Van den Bosch; G Locatelli; L Geerts; G Fagà; M Ieven; H Goossens; D Bottiger; B Oberg; P Lusso; Z N Berneman
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.

Authors:  Nahid Akhyani; Julie Fotheringham; Karen Yao; Farzin Rashti; Steven Jacobson
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

8.  Cell Culture Systems To Study Human Herpesvirus 6A/B Chromosomal Integration.

Authors:  Annie Gravel; Isabelle Dubuc; Nina Wallaschek; Shella Gilbert-Girard; Vanessa Collin; Ruth Hall-Sedlak; Keith R Jerome; Yasuko Mori; Julie Carbonneau; Guy Boivin; Benedikt B Kaufer; Louis Flamand
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

9.  Trafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes.

Authors:  L Menotti; P Mirandola; M Locati; G Campadelli-Fiume
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 10.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.